What are the differences between HSV‑1 and HSV‑2 regarding typical outbreak locations, triggers, and recommended antiviral treatment?

Herpes Types and Outbreaks

HSV-1 primarily causes oral infections but increasingly causes genital herpes (especially in first episodes), while HSV-2 predominantly causes genital infections with more frequent recurrences; both types respond to the same antiviral regimens (acyclovir, valacyclovir, or famciclovir), though HSV-2 genital infections recur far more often than HSV-1 genital infections.

Key Differences Between HSV-1 and HSV-2

Typical Outbreak Locations

HSV-1:

• Traditionally associated with oro-labial infections (cold sores) with latency in cervical ganglia 1
• Increasingly causes genital herpes, now accounting for 5-30% of first-episode genital infections and over half of new genital infections in some populations 2, 3
• Can infect eyes, oro-pharynx, and rectal mucosa 1

HSV-2:

• Nearly exclusively causes genital infections with latency in sacral ganglia 1, 3
• Affects genitalia, urogenital tract, perianal skin, rectum, buttocks, and thighs 1
• Rarely causes oral infections

Recurrence Patterns and Triggers

Critical distinction: HSV-2 genital infections recur much more frequently than HSV-1 genital infections 2, 3. This has major implications for patient counseling and management decisions.

Recurrence frequency:

• Ranges from once every few years to several times per month 1
• HSV-2 causes more frequent asymptomatic viral shedding than HSV-1, particularly in the first 12 months after infection 2
• Most patients with first-episode HSV-2 genital infection will have recurrent episodes 2

Outbreak characteristics:

• Recurrent lesions typically appear at the same location as primary infection 1
• Episodes last less than 10 days unless complicated by secondary bacterial infection or immunosuppression 1
• Classic progression: redness → papules → vesicles with infectious viral particles → ulcers/erosions → crusting → healing without scars 1

Antiviral Treatment Recommendations

First Clinical Episode (Primary Infection)

For 7-10 days 2:

• Acyclovir 400 mg orally three times daily, OR
• Acyclovir 200 mg orally five times daily, OR
• Famciclovir 250 mg orally three times daily, OR
• Valacyclovir 1 g orally twice daily

Note: Treatment may be extended if healing is incomplete after 10 days 2

Recurrent Episodes (Episodic Therapy)

For 5 days 2:

• Acyclovir 400 mg orally three times daily, OR
• Acyclovir 200 mg orally five times daily, OR
• Acyclovir 800 mg orally twice daily, OR
• Famciclovir 125 mg orally twice daily, OR
• Valacyclovir 500 mg orally twice daily

Key timing: Start treatment during prodrome or within 1 day of lesion onset for maximum benefit 2

Suppressive Therapy (Daily)

Indications: Patients with ≥6 recurrences per year benefit most; reduces recurrence frequency by ≥75% 2

Regimens 2:

• Acyclovir 400 mg orally twice daily (documented safe for up to 6 years)
• Famciclovir 250 mg orally twice daily
• Valacyclovir 250 mg orally twice daily, OR
• Valacyclovir 500 mg orally once daily, OR
• Valacyclovir 1,000 mg orally once daily

Important caveat: Valacyclovir 500 mg once daily is less effective in patients with ≥10 episodes per year 2

Severe Disease

For hospitalized patients with disseminated infection, pneumonitis, hepatitis, meningitis, or encephalitis 2:

• Acyclovir 5-10 mg/kg IV every 8 hours for 5-7 days or until clinical resolution

Critical Clinical Considerations

Asymptomatic Viral Shedding

• Occurs more frequently with HSV-2 than HSV-1 2
• Most common mode of transmission 4
• Suppressive therapy reduces but does not eliminate shedding 2
• 80-90% of genital herpes cases progress subclinically but may become symptomatic at any time 1

Special Populations

Pregnancy:

• Antiviral prophylaxis (acyclovir/valacyclovir) recommended from 36 weeks gestation until delivery in women with history of genital herpes 5, 6
• Cesarean delivery indicated for active lesions during labor to prevent neonatal herpes 5

HIV-infected patients:

• May require higher doses (acyclovir 400 mg orally 3-5 times daily) 2
• Famciclovir 500 mg twice daily effective for decreasing recurrences and subclinical shedding 2

Counseling Essentials

Patients must understand 2:

• Lifelong infection with potential for recurrent episodes
• Asymptomatic viral shedding and transmission risk
• Abstain from sexual activity when lesions or prodromal symptoms present
• Condom use with new or uninfected partners
• HSV-2 increases HIV acquisition risk 3-fold 3
• Frequency of recurrences typically decreases over time 2